Preparation Methods for a New Generation of Biologically Safe KLH Products Used for Cancer Treatment, for the Development of Conjugated Therapeutic Vaccines, and as Provocation Test Substances

摘要

The present invention relates to the provision of a biologically safe hemolymph sera, preferably hemocyanin, more preferably KLH (keyhole limpet hemocyanin). The hemocyanin is purified using anion exchange chromatography.